Multicenter Studies as Topic

"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.

Descriptor ID	D015337
MeSH Number(s)	E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
Concept/Terms	Multicenter Studies as Topic Multicenter Studies as Topic Multicentre Studies as Topic Multicenter Trials Multicenter Trials Multicenter Trial Trial, Multicenter Trials, Multicenter Multicentre Trials Multicentre Trial Trial, Multicentre Trials, Multicentre

Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Multicenter Studies as Topic [E05.318.760.658]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Multicenter Studies as Topic [N05.715.360.775.508]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Multicenter Studies as Topic [N06.850.520.450.643]

Below are MeSH descriptors whose meaning is related to "Multicenter Studies as Topic".

Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.

Bar chart showing 333 publications over 29 distinct years, with a maximum of 29 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1990	0	9	9
1992	0	1	1
1993	1	1	2
1994	1	2	3
1995	0	3	3
1996	0	7	7
1997	1	3	4
1998	0	6	6
1999	0	5	5
2000	1	9	10
2001	1	9	10
2002	1	13	14
2003	1	17	18
2004	0	21	21
2005	1	11	12
2006	2	27	29
2007	0	10	10
2008	2	14	16
2009	1	18	19
2010	1	14	15
2011	0	15	15
2012	0	11	11
2013	3	14	17
2014	1	13	14
2015	0	10	10
2016	1	9	10
2017	2	13	15
2018	1	13	14
2019	0	13	13

Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.

Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM. KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.

View in: PubMed
Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS. The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. JACC Cardiovasc Interv. 2019 10 14; 12(19):1985-1987.

View in: PubMed
Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 04; 203(4):684-689.

View in: PubMed
Molica M, Breccia M, Foa R, Jabbour E, Kadia TM. Maintenance therapy in AML: The past, the present and the future. Am J Hematol. 2019 11; 94(11):1254-1265.

View in: PubMed
Ferreira JP, Rossignol P, Dewan P, Lamiral Z, White WB, Pitt B, McMurray JJV, Zannad F. Income level and inequality as complement to geographical differences in cardiovascular trials. Am Heart J. 2019 12; 218:66-74.

View in: PubMed
Hasegawa K, Goto T, Hirayama A, Laham FR, Mansbach JM, Piedra PA, Camargo CA. Respiratory Virus Epidemiology Among US Infants With Severe Bronchiolitis: Analysis of 2 Multicenter, Multiyear Cohort Studies. Pediatr Infect Dis J. 2019 08; 38(8):e180-e183.

View in: PubMed
Borow KM, Yaroshinsky A, Greenberg B, Perin EC. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circ Res. 2019 07 19; 125(3):265-281.

View in: PubMed
Roos N, Lambach P, Mantel C, Mason E, Muñoz FM, Giles M, Moran A, Hombach J, Diaz T. Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality. BMJ Open. 2019 06 04; 9(6):e024449.

View in: PubMed
Loor G, Parulekar A, Smith M. Evaluation of the INSPIRE trial and its implications for lung transplantation with normothermic portable ex vivo lung perfusion. J Thorac Cardiovasc Surg. 2019 10; 158(4):1259-1263.

View in: PubMed
Pina LM, Dong X, Zhang L, Samtani MN, Michelson AD, Justino H, Bonnet D, Harris KC, Jefferies J, McCrindle BW, Li JS. Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study). Am Heart J. 2019 07; 213:97-104.

View in: PubMed

People

Explore

Similar Concepts

Top Journals